Management of newly diagnosed glioblastoma: guidelines development, value and application (Q37476857)

20 August 2017

1 reference

title

Management of newly diagnosed glioblastoma: guidelines development, value and application (English)

1 reference

20 August 2017

1 reference

1

Jeffrey J Olson

1 reference

20 August 2017

Camilo E Fadul

2

1 reference

20 August 2017

Daniel J Brat

series ordinal

3

1 reference

20 August 2017

Srinivasan Mukundan

series ordinal

4

1 reference

20 August 2017

Timothy C Ryken

series ordinal

5

1 reference

20 August 2017

publication date

9 May 2009

1 reference

Journal of Neuro-Oncology

20 August 2017

published in

1 reference

20 August 2017

volume

93

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

1-23

1 reference

Gliomas: classification with MR imaging

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Cell proliferation and tumors of the central nervous system, part II: radiolabeling, cytometric, and immunohistochemical techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Misonidazole combined with hyperfractionation in the management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Patterns of second recurrence of malignant astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9838-Z

Grading of astrocytomas. A simple and reproducible method.

21 January 2018

1 reference

12 December 2020

Perfusion MR imaging in gliomas: comparison with histologic tumor grade

1 reference

12 December 2020

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

1 reference

12 December 2020

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

1 reference

12 December 2020

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

12 December 2020

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

12 December 2020

Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique

1 reference

12 December 2020

Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis

1 reference

12 December 2020

Radiotherapy of malignant glioma--prospective randomized clinical study of whole brain vs local irradiation

1 reference

12 December 2020

Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors

1 reference

12 December 2020

PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization

1 reference

12 December 2020

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

12 December 2020

Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.

1 reference

12 December 2020

Mechanisms of disease: genetic predictors of response to treatment in brain tumors

1 reference

12 December 2020

Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.

1 reference

12 December 2020

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

1 reference

12 December 2020

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

1 reference

12 December 2020

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

1 reference

12 December 2020

Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading.

1 reference

12 December 2020

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 reference

12 December 2020

Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study

1 reference

12 December 2020

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

1 reference

12 December 2020

Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers

1 reference

12 December 2020

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials

1 reference

12 December 2020

Dual repair modulation reverses Temozolomide resistance in vitro.

1 reference

12 December 2020

A prospective study on glioblastoma in the elderly

1 reference

12 December 2020

Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours.

1 reference

12 December 2020

Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.

1 reference

12 December 2020

Update from funders. Center for Primary Care Research and Agency for Health Care Research and Quality

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

1 reference

12 December 2020

Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 reference

12 December 2020

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

12 December 2020

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine

1 reference

12 December 2020

Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

1 reference

12 December 2020

ACR appropriateness criteria

1 reference

12 December 2020

Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

1 reference

12 December 2020

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

1 reference

12 December 2020

Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.

1 reference

12 December 2020

Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).

1 reference

12 December 2020

Superfractionated radiotherapy in grade III, IV intracranial gliomas

1 reference

12 December 2020

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

1 reference

12 December 2020

Gene amplification as a prognostic factor in primary brain tumors

1 reference

12 December 2020

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

12 December 2020

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

12 December 2020

Chemopotentiation by PARP inhibitors in cancer therapy.

1 reference

12 December 2020

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

1 reference

12 December 2020

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

12 December 2020

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

12 December 2020

The 2007 WHO classification of tumours of the central nervous system

1 reference

12 December 2020

In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.

1 reference

12 December 2020

A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma

1 reference

12 December 2020

Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis

1 reference

12 December 2020

Quality of randomized controlled trials reporting in the primary treatment of brain tumors

1 reference

12 December 2020

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery

1 reference

12 December 2020

Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults

1 reference

12 December 2020

Neuroradiological assessment of newly diagnosed glioblastoma

1 reference

12 December 2020

Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma

1 reference

12 December 2020

Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.

1 reference

12 December 2020

Stereotactic brain biopsies: specimen preparation and evaluation

1 reference

12 December 2020

Diagnosis of malignant glioma: role of neuropathology

1 reference

12 December 2020

Role of MIB1 in predicting survival in patients with glioblastomas

1 reference

12 December 2020

Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

12 December 2020

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

1 reference

12 December 2020

Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics

1 reference

12 December 2020

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

12 December 2020

Limitations of stereotactic biopsy in the initial management of gliomas.

1 reference

12 December 2020

Debulking or biopsy of malignant glioma in elderly people - a randomised study

1 reference

12 December 2020

Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections

1 reference

12 December 2020

Identification of human brain tumour initiating cells

1 reference

12 December 2020

Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma

1 reference

12 December 2020

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

1 reference

12 December 2020

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

1 reference

12 December 2020

Touch preparations in the rapid intraoperative diagnosis of central nervous system lesions. A comparison with frozen sections and paraffin-embedded sections

1 reference

12 December 2020

Targeted molecular therapy of malignant gliomas

1 reference

12 December 2020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

12 December 2020

Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

12 December 2020

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

12 December 2020

Superfractionation radiation therapy in the treatment of malignant astrocytoma

1 reference

12 December 2020

Imprints, smears, and frozen sections of brain tumors

1 reference

12 December 2020

Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions

1 reference

12 December 2020

The reliability of computer tomography for the diagnosis and differential diagnosis of meningiomas, gliomas, and brain metastases

1 reference

12 December 2020

The Measurement of Observer Agreement for Categorical Data

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

Extent of resection as a prognostic variable in the treatment of gliomas

1 reference

12 December 2020

Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

1 reference

12 December 2020

The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine

1 reference

12 December 2020

Cellular proliferation in pilocytic and diffuse astrocytomas

1 reference

12 December 2020

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

12 December 2020

Central nervous system cancers

1 reference

12 December 2020

Accuracy of grading gliomas on CT-guided stereotactic biopsies: a survival analysis

1 reference

12 December 2020

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery.

1 reference

12 December 2020

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results

1 reference

12 December 2020

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

1 reference

12 December 2020

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

12 December 2020

10.1007/S11060-009-9838-Z

Identifiers

DOI

1 reference

20 August 2017

1 reference